Skip to main content
Top
Published in: Translational Neurodegeneration 1/2015

Open Access 01-12-2015 | Research

Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis

Authors: Honglei Chen, Edward J Zhao, Wen Zhang, Yi Lu, Rui Liu, Xuemei Huang, Anna J Ciesielski-Jones, Michele A Justice, Deborah S Cousins, Shyamal Peddada

Published in: Translational Neurodegeneration | Issue 1/2015

Login to get access

Abstract

Background

Nonmotor symptoms are common among patients with Parkinson’s disease (PD) and some may precede disease diagnosis.

Methods

We conducted a meta-analysis on the prevalence of selected nonmotor symptoms before and after PD diagnosis, using random-effect models. We searched PubMed (1965 through October/November 2012) for the following symptoms: hyposmia, constipation, rapid eye movement sleep behavior disorder, excessive daytime sleepiness, depression, and anxiety. Eligible studies were publications in English with original data on one or more of these symptoms.

Results

The search generated 2,373 non-duplicated publications and 332 met the inclusion criteria, mostly (n = 320) on symptoms after PD diagnosis. For all symptoms, the prevalence was substantially higher in PD cases than in controls, each affecting over a third of the patients. Hyposmia was the most prevalent (75.5% in cases vs. 19.1% in controls), followed by constipation (50% vs. 17.7%), anxiety (39.9% vs. 19.1%), rapid eye movement sleep behavior disorder (37.0% vs. 7.0%), depression (36.6% vs. 14.9%), and excessive daytime sleepiness (33.9% vs. 10.5%). We observed substantial heterogeneities across studies and meta-regression analyses suggested that several factors might have contributed to this. However, the prevalence estimates were fairly robust in several sensitivity analyses. Only 20 studies had data on any symptoms prior to PD diagnosis, but still the analyses revealed higher prevalence in future PD cases than in controls.

Conclusion

These symptoms are common among PD patients both before and after diagnosis. Further studies are needed to understand the natural history of nonmotor symptoms in PD and their etiological and clinical implications.
Appendix
Available only for authorised users
Literature
1.
go back to reference Soh SE, Morris ME, McGinley JL: Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011,17(1):1–9. 10.1016/j.parkreldis.2010.08.012CrossRefPubMed Soh SE, Morris ME, McGinley JL: Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2011,17(1):1–9. 10.1016/j.parkreldis.2010.08.012CrossRefPubMed
2.
go back to reference Lang AE: A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 2011,26(5):775–83. 10.1002/mds.23609CrossRefPubMed Lang AE: A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 2011,26(5):775–83. 10.1002/mds.23609CrossRefPubMed
3.
go back to reference Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al.: Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008,63(2):167–73. 10.1002/ana.21291CrossRefPubMed Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al.: Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008,63(2):167–73. 10.1002/ana.21291CrossRefPubMed
4.
go back to reference Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, et al.: Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007,22(11):1581–6. 10.1002/mds.21560CrossRefPubMed Abbott RD, Ross GW, Petrovitch H, Tanner CM, Davis DG, Masaki KH, et al.: Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 2007,22(11):1581–6. 10.1002/mds.21560CrossRefPubMed
5.
go back to reference Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, et al.: Medical records documentation of constipation preceding Parkinson disease: A case–control study. Neurology 2009,73(21):1752–8. 10.1212/WNL.0b013e3181c34af5CrossRefPubMedCentralPubMed Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, et al.: Medical records documentation of constipation preceding Parkinson disease: A case–control study. Neurology 2009,73(21):1752–8. 10.1212/WNL.0b013e3181c34af5CrossRefPubMedCentralPubMed
6.
go back to reference Gao X, Chen H, Schwarzschild MA, Ascherio A: A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol 2011,174(5):546–51. 10.1093/aje/kwr119CrossRefPubMedCentralPubMed Gao X, Chen H, Schwarzschild MA, Ascherio A: A prospective study of bowel movement frequency and risk of Parkinson's disease. Am J Epidemiol 2011,174(5):546–51. 10.1093/aje/kwr119CrossRefPubMedCentralPubMed
7.
go back to reference Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, et al.: Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010,25(13):2105–13. 10.1002/mds.23230CrossRefPubMedCentralPubMed Bower JH, Grossardt BR, Maraganore DM, Ahlskog JE, Colligan RC, Geda YE, et al.: Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord 2010,25(13):2105–13. 10.1002/mds.23230CrossRefPubMedCentralPubMed
8.
go back to reference Fang F, Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, et al.: Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord 2010,25(9):1157–62. 10.1002/mds.23092CrossRefPubMedCentralPubMed Fang F, Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, et al.: Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study. Mov Disord 2010,25(9):1157–62. 10.1002/mds.23092CrossRefPubMedCentralPubMed
9.
go back to reference Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A: Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003,18(6):646–51. 10.1002/mds.10425CrossRefPubMed Weisskopf MG, Chen H, Schwarzschild MA, Kawachi I, Ascherio A: Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord 2003,18(6):646–51. 10.1002/mds.10425CrossRefPubMed
10.
go back to reference Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF: REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010,75(6):494–9. 10.1212/WNL.0b013e3181ec7facCrossRefPubMedCentralPubMed Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF: REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010,75(6):494–9. 10.1212/WNL.0b013e3181ec7facCrossRefPubMedCentralPubMed
11.
go back to reference Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J: Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009,72(15):1296–300. 10.1212/01.wnl.0000340980.19702.6eCrossRefPubMedCentralPubMed Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J: Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009,72(15):1296–300. 10.1212/01.wnl.0000340980.19702.6eCrossRefPubMedCentralPubMed
12.
go back to reference Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, et al.: Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005,65(9):1442–6. 10.1212/01.wnl.0000183056.89590.0dCrossRefPubMed Abbott RD, Ross GW, White LR, Tanner CM, Masaki KH, Nelson JS, et al.: Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005,65(9):1442–6. 10.1212/01.wnl.0000183056.89590.0dCrossRefPubMed
13.
go back to reference Gao J, Huang X, Park Y, Hollenback A, Blair A, Schatzkin A, et al.: Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 2011,173(9):1032–8. 10.1093/aje/kwq478CrossRefPubMedCentralPubMed Gao J, Huang X, Park Y, Hollenback A, Blair A, Schatzkin A, et al.: Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 2011,173(9):1032–8. 10.1093/aje/kwq478CrossRefPubMedCentralPubMed
14.
go back to reference Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Tredici KD: Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Movement Disorders 2006,21(12):2042–51. 10.1002/mds.21065CrossRefPubMed Braak H, Bohl JR, Müller CM, Rüb U, de Vos RAI, Tredici KD: Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Movement Disorders 2006,21(12):2042–51. 10.1002/mds.21065CrossRefPubMed
15.
go back to reference Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbot R, et al.: Research on the Premotor Symptoms of Parkinson's Disease: Clinical and Etiological Implications. Environ Health Perspect 2013,121(11–12):1245–52.PubMedCentralPubMed Chen H, Burton EA, Ross GW, Huang X, Savica R, Abbot R, et al.: Research on the Premotor Symptoms of Parkinson's Disease: Clinical and Etiological Implications. Environ Health Perspect 2013,121(11–12):1245–52.PubMedCentralPubMed
16.
go back to reference Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al.: The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009,24(11):1641–9. 10.1002/mds.22643CrossRefPubMed Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al.: The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009,24(11):1641–9. 10.1002/mds.22643CrossRefPubMed
17.
go back to reference Herting B, Schulze S, Reichmann H, Haehner A, Hummel T: A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 2008,255(3):367–70. 10.1007/s00415-008-0665-5CrossRefPubMed Herting B, Schulze S, Reichmann H, Haehner A, Hummel T: A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 2008,255(3):367–70. 10.1007/s00415-008-0665-5CrossRefPubMed
18.
go back to reference Herlofson K, Ongre SO, Enger LK, Tysnes OB, Larsen JP: Fatigue in early Parkinson's disease. Minor inconvenience or major distress? Eur J Neurol 2012,19(7):963–8. 10.1111/j.1468-1331.2012.03663.xCrossRefPubMed Herlofson K, Ongre SO, Enger LK, Tysnes OB, Larsen JP: Fatigue in early Parkinson's disease. Minor inconvenience or major distress? Eur J Neurol 2012,19(7):963–8. 10.1111/j.1468-1331.2012.03663.xCrossRefPubMed
19.
go back to reference Gupta A, Bhatia S: Psychological functioning in patients with Parkinson's disease. Parkinsonism Relat Disord 2000,6(3):185–90. 10.1016/S1353-8020(00)00010-9CrossRefPubMed Gupta A, Bhatia S: Psychological functioning in patients with Parkinson's disease. Parkinsonism Relat Disord 2000,6(3):185–90. 10.1016/S1353-8020(00)00010-9CrossRefPubMed
20.
go back to reference Chew V: Point Estimation of the Parameter of the Binomial Distribution. The American Statistician 1971,25(5):47–50. Chew V: Point Estimation of the Parameter of the Binomial Distribution. The American Statistician 1971,25(5):47–50.
21.
go back to reference Lipsey MW, Wilson DB: Practical Meta-Analysis. London: SAGE Publicaitons; 2000. Lipsey MW, Wilson DB: Practical Meta-Analysis. London: SAGE Publicaitons; 2000.
22.
go back to reference Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002,21(11):1539–58. 10.1002/sim.1186CrossRefPubMed Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002,21(11):1539–58. 10.1002/sim.1186CrossRefPubMed
23.
go back to reference Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. Bmj 1997,315(7109):629–34. 10.1136/bmj.315.7109.629CrossRefPubMedCentralPubMed Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. Bmj 1997,315(7109):629–34. 10.1136/bmj.315.7109.629CrossRefPubMedCentralPubMed
24.
go back to reference Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovanni G, Lees AJ, et al.: Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012,72(6):893–901. 10.1002/ana.23687CrossRefPubMedCentralPubMed Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovanni G, Lees AJ, et al.: Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012,72(6):893–901. 10.1002/ana.23687CrossRefPubMedCentralPubMed
25.
go back to reference Duncan GW, Khoo TK, Yarnall AJ, O’Brien JT, Coleman SY, Brooks DJ, et al.: Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov Disord 2013,29(2):195–202.CrossRefPubMed Duncan GW, Khoo TK, Yarnall AJ, O’Brien JT, Coleman SY, Brooks DJ, et al.: Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms. Mov Disord 2013,29(2):195–202.CrossRefPubMed
26.
go back to reference Berg D, Marek K, Ross GW, Poewe W: Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov Disord 2012,27(5):656–65. 10.1002/mds.24985CrossRefPubMed Berg D, Marek K, Ross GW, Poewe W: Defining at-risk populations for Parkinson's disease: lessons from ongoing studies. Mov Disord 2012,27(5):656–65. 10.1002/mds.24985CrossRefPubMed
27.
go back to reference Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, et al.: Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 2012,27(3):406–12. 10.1002/mds.24892CrossRefPubMed Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, et al.: Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord 2012,27(3):406–12. 10.1002/mds.24892CrossRefPubMed
28.
go back to reference Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S, et al.: The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 2013,20(1):102–8. 10.1111/j.1468-1331.2012.03798.xCrossRefPubMed Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S, et al.: The PRIPS study: screening battery for subjects at risk for Parkinson's disease. Eur J Neurol 2013,20(1):102–8. 10.1111/j.1468-1331.2012.03798.xCrossRefPubMed
29.
go back to reference Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, et al.: Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol 2014,21(5):766–72. 10.1111/ene.12382CrossRefPubMed Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, et al.: Prodromal features for Parkinson's disease--baseline data from the TREND study. Eur J Neurol 2014,21(5):766–72. 10.1111/ene.12382CrossRefPubMed
30.
go back to reference Hawkes CH, Del Tredici K, Braak H: Parkinson's disease: the dual hit theory revisited. Ann N Y Acad Sci 2009, 1170:615–22. 10.1111/j.1749-6632.2009.04365.xCrossRefPubMed Hawkes CH, Del Tredici K, Braak H: Parkinson's disease: the dual hit theory revisited. Ann N Y Acad Sci 2009, 1170:615–22. 10.1111/j.1749-6632.2009.04365.xCrossRefPubMed
31.
go back to reference Reichmann H: View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication. J Neurol Sci 2011,310(1–2):9–11.PubMed Reichmann H: View point: Etiology in Parkinson's disease. Dual hit or spreading intoxication. J Neurol Sci 2011,310(1–2):9–11.PubMed
32.
go back to reference Postuma RB, Montplaisir JY, Pelletier A, Dauvilliers Y, Oertel W, Iranzo A, et al.: Environmental risk factors for REM sleep behavior disorder: a multicenter case–control study. Neurology 2012,79(5):428–34. 10.1212/WNL.0b013e31825dd383CrossRefPubMedCentralPubMed Postuma RB, Montplaisir JY, Pelletier A, Dauvilliers Y, Oertel W, Iranzo A, et al.: Environmental risk factors for REM sleep behavior disorder: a multicenter case–control study. Neurology 2012,79(5):428–34. 10.1212/WNL.0b013e31825dd383CrossRefPubMedCentralPubMed
33.
go back to reference Chen H, Huang X, Guo X, Peddada S: Individual and joint prevalence of three nonmotor symptoms of PD in the US general population. Mov Disord 2014,29(10):1316–9. 10.1002/mds.25950CrossRefPubMed Chen H, Huang X, Guo X, Peddada S: Individual and joint prevalence of three nonmotor symptoms of PD in the US general population. Mov Disord 2014,29(10):1316–9. 10.1002/mds.25950CrossRefPubMed
34.
go back to reference Postuma RB, Gagnon JF, Montplaisir JY: REM sleep behavior disorder: from dreams to neurodegeneration. Neurobiol Dis 2012,46(3):553–8. 10.1016/j.nbd.2011.10.003CrossRefPubMed Postuma RB, Gagnon JF, Montplaisir JY: REM sleep behavior disorder: from dreams to neurodegeneration. Neurobiol Dis 2012,46(3):553–8. 10.1016/j.nbd.2011.10.003CrossRefPubMed
35.
go back to reference Hummel T, Konnerth CG, Rosenheim K, Kobal G: Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001,110(10):976–81. 10.1177/000348940111001015CrossRefPubMed Hummel T, Konnerth CG, Rosenheim K, Kobal G: Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001,110(10):976–81. 10.1177/000348940111001015CrossRefPubMed
36.
go back to reference Doty RL, Marcus A, Lee WW: Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996,106(3 Pt 1):353–6.CrossRefPubMed Doty RL, Marcus A, Lee WW: Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996,106(3 Pt 1):353–6.CrossRefPubMed
37.
go back to reference Suares NC, Ford AC: Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011,106(9):1582–91. 10.1038/ajg.2011.164CrossRefPubMed Suares NC, Ford AC: Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol 2011,106(9):1582–91. 10.1038/ajg.2011.164CrossRefPubMed
38.
go back to reference Volkert J, Schulz H, Harter M, Wlodarczyk O, Andreas S: The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Res Rev 2013,12(1):339–53. 10.1016/j.arr.2012.09.004CrossRefPubMed Volkert J, Schulz H, Harter M, Wlodarczyk O, Andreas S: The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Res Rev 2013,12(1):339–53. 10.1016/j.arr.2012.09.004CrossRefPubMed
39.
go back to reference Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM: Prevalence of olfactory impairment in older adults. Jama 2002,288(18):2307–12. 10.1001/jama.288.18.2307CrossRefPubMed Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM: Prevalence of olfactory impairment in older adults. Jama 2002,288(18):2307–12. 10.1001/jama.288.18.2307CrossRefPubMed
Metadata
Title
Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis
Authors
Honglei Chen
Edward J Zhao
Wen Zhang
Yi Lu
Rui Liu
Xuemei Huang
Anna J Ciesielski-Jones
Michele A Justice
Deborah S Cousins
Shyamal Peddada
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Translational Neurodegeneration / Issue 1/2015
Electronic ISSN: 2047-9158
DOI
https://doi.org/10.1186/2047-9158-4-1

Other articles of this Issue 1/2015

Translational Neurodegeneration 1/2015 Go to the issue